
Sanofi plans to create a new company in Europe dedicated to the production and marketing of active pharmaceutical ingredients (API). …
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns
How will biomarker-led diagnostics reshape respiratory medicine?

